Cellectis S.A. (CMVLF)
USD 2.54
(0.0%)
USD 2.54
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -25.6 Million | -87.44 Million | -104.56 Million | -80.26 Million | -69.14 Million | -68.13 Million |
| Net Income | -111.74 Million | -98.68 Million | -125.1 Million | -97.48 Million | -115.21 Million | -88.33 Million |
| Depreciation & Amortization | 18.91 Million | 18.43 Million | 16.57 Million | 9.81 Million | 6.87 Million | 2.37 Million |
| Deferred income taxes | 371 Thousand | 87 Thousand | 590 Thousand | 468 Thousand | 8.91 Million | 6.45 Million |
| Stock-based compensation | 5.23 Million | 6.04 Million | 11.49 Million | 10.02 Million | 26.88 Million | 37.21 Million |
| Change in working capital | 49.88 Million | -5.72 Million | -4.16 Million | -21.82 Million | 11.65 Million | -9.09 Million |
| Other non-cash items | 67.97 Million | -7.59 Million | -5.57 Million | 12.02 Million | -8.25 Million | -16.76 Million |
| Investing Cash Flow | -15.83 Million | -2.76 Million | 7.27 Million | -54.34 Million | -35.87 Million | 35.62 Million |
| Investments in PPE | -1.09 Million | -2.44 Million | -19.74 Million | -46.26 Million | -12.95 Million | -4.88 Million |
| Acquisitions | -1.67 Million | - | -14.27 Million | 57.95 Thousand | 415.2 Thousand | 1.22 Million |
| Investment purchases | -13.64 Million | - | -137.51 Thousand | -8.13 Million | -23.39 Million | - |
| Sales/Maturities of investments | 499.23 Thousand | 126 Thousand | 14.42 Million | 4.99 Million | 23.02 Million | 39.24 Million |
| Other Investing Activities | 80.65 Thousand | -446 Thousand | 27 Million | -5 Million | -22.95 Million | 1.26 Million |
| Financing Cash Flow | 84.93 Million | 1.14 Million | 47.52 Million | 27.32 Million | -3.86 Million | 236.49 Million |
| Debt repayment | -25.07 Million | -12.35 Million | -12.46 Million | -6.6 Million | -3.39 Million | -127 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -569 Thousand | - | - | -469 Thousand | - |
| Common Stock Issuance | 69.35 Million | -579.43 Thousand | 48.51 Million | 9.2 Million | - | 236.62 Million |
| Other Financing Activities | 1.81 Million | 15.22 Million | 11.47 Million | 24.72 Million | -3.86 Million | 236.62 Million |
| Accounts receivables | -6.36 Million | -3.18 Million | -5.83 Million | -8.33 Million | -2.67 Million | -3.69 Million |
| Accounts payables | -6.43 Million | 3.24 Million | -444 Thousand | 5.8 Million | 9.63 Million | 9.37 Million |
| Inventory | - | -5.8 Million | 1.59 Million | 1.31 Million | -2.62 Million | -37 Thousand |
| Other working capital | 62.68 Million | 23 Thousand | 515 Thousand | -20.6 Million | 7.32 Million | -14.73 Million |
| Cash at beginning of period | 90.24 Million | 185.63 Million | 241.14 Million | 340.52 Million | 451.5 Million | 256.38 Million |
| Cash at end of period | 136.59 Million | 93.21 Million | 185.63 Million | 241.14 Million | 340.52 Million | 451.5 Million |
| Capital Expenditure | -1.09 Million | -2.44 Million | -19.74 Million | -46.26 Million | -12.95 Million | -4.88 Million |
| Effect of forex changes on cash | 884 Thousand | -3.36 Million | -5.75 Million | 7.9 Million | -2.1 Million | -8.86 Million |
| Net cash flow / Change in cash | 46.35 Million | -92.42 Million | -55.51 Million | -99.37 Million | -110.97 Million | 195.12 Million |
| Free Cash Flow | -26.69 Million | -89.88 Million | -124.3 Million | -126.52 Million | -82.1 Million | -73.02 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -25.14 Million | 5.6 Million | -63.25 Million | -111.74 Million | -17.48 Million | -7.89 Million |
| Depreciation & Amortization | 4.7 Million | 4.54 Million | 5.31 Million | 18.91 Million | 4.46 Million | 4.41 Million |
| Deferred income taxes | -193 Thousand | -262 Thousand | 6000.00 | 371 Thousand | 107 Thousand | -453 Thousand |
| Stock-based compensation | 830 Thousand | 887 Thousand | 4.62 Million | 5.23 Million | -2.65 Million | 1.64 Million |
| Change in working capital | 60.42 Million | -8.83 Million | 60.28 Million | 49.88 Million | 731 Thousand | -588 Thousand |
| Other non-cash items | -45.05 Million | 3.6 Million | 57.43 Million | 67.97 Million | -2.26 Million | -16.16 Million |
| Investing Cash Flow | -105.47 Million | -2.03 Million | -13.93 Million | -15.83 Million | -300 Thousand | -1.78 Million |
| Investments in PPE | -993.02 Thousand | -253.5 Thousand | -281.36 Thousand | -1.09 Million | -314 Thousand | -270 Thousand |
| Acquisitions | -36.66 Thousand | - | -14.47 Thousand | -1.67 Million | 14.64 Thousand | -1.65 Million |
| Investment purchases | -104.44 Million | -1.78 Million | -13.64 Million | -13.64 Million | -14.65 Thousand | 1.51 Million |
| Sales/Maturities of investments | - | - | -252.63 | 499.23 Thousand | 8.03 | 141.85 Thousand |
| Other Investing Activities | -986.89 | 994.15 | 2002.07 | 80.65 Thousand | 14 Thousand | -1.51 Million |
| Financing Cash Flow | 78.01 Million | 12.05 Million | 42.53 Million | 84.93 Million | 1.68 Million | 19.81 Million |
| Debt repayment | -1.27 Million | -14.84 Million | -102.73 Thousand | -25.07 Million | -4.06 Million | -4.06 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -1.4 Million | - |
| Common Stock Issuance | 82.07 Million | - | 45.23 Million | 69.35 Million | 53 Thousand | 176 Thousand |
| Other Financing Activities | 82.66 Million | -226 Thousand | -920.10 | 1.81 Million | 8.5 Million | 23.7 Million |
| Accounts receivables | 60.78 Million | -13.38 Million | -6.87 Million | -6.36 Million | -497 Thousand | 2.27 Million |
| Accounts payables | 5.14 Million | -5.85 Million | -1.79 Million | -6.43 Million | 2.89 Million | -1.23 Million |
| Inventory | - | - | - | - | -1.54 Million | -1.53 Million |
| Other working capital | -5.51 Million | 10.39 Million | 68.95 Million | 62.68 Million | -121 Thousand | -98 Thousand |
| Cash at beginning of period | 122.85 Million | 136.59 Million | 67.25 Million | 90.24 Million | 84.38 Million | 85.57 Million |
| Cash at end of period | 148.95 Million | 122.85 Million | 136.59 Million | 136.59 Million | 67.35 Million | 84.38 Million |
| Capital Expenditure | -993.02 Thousand | -253.5 Thousand | -281.36 Thousand | -1.09 Million | -314 Thousand | -270 Thousand |
| Effect of forex changes on cash | 1.8 Million | -267 Thousand | 1.7 Million | 884 Thousand | -1.32 Million | -170 Thousand |
| Net cash flow / Change in cash | 26.09 Million | -13.73 Million | 69.34 Million | 46.35 Million | -17.02 Million | -1.18 Million |
| Free Cash Flow | 50.45 Million | -23.65 Million | 40.19 Million | -26.69 Million | -17.4 Million | -19.31 Million |
YES
MSKE
6825
NIRO
HLMS
6473